Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04597762Completed
Randomised trial of cyclosporine in keratoconjunctivitis sicca (KCS) (2 arms), sponsored by Klinik Hietzing. Primary endpoints: Tear Film Breakup Time at 6 months, Corneal Fluorescein Staining at 6 months and 1 more. Started Aug 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04597762.